-
1
-
-
30144445801
-
Prolonged-release nicotinic acid a review of its use in the treatment of dyslipidaemia
-
McCormack P.L., and Keating G.M. Prolonged-release nicotinic acid a review of its use in the treatment of dyslipidaemia. Drugs 65 (2005) 2719-2740
-
(2005)
Drugs
, vol.65
, pp. 2719-2740
-
-
McCormack, P.L.1
Keating, G.M.2
-
2
-
-
4544281690
-
The mechanism of nicotinuric acid synthesis
-
Jones K.M. The mechanism of nicotinuric acid synthesis. Biochem J 73 (1959) 714-719
-
(1959)
Biochem J
, vol.73
, pp. 714-719
-
-
Jones, K.M.1
-
3
-
-
1642458398
-
Enzymology of NAD+ homeostasis in man
-
Magni G., Amici A., Emanuelli M., Orsomando G., Raffaelli N., and Ruggieri S. Enzymology of NAD+ homeostasis in man. Cell Mol Life Sci 61 (2004) 19-34
-
(2004)
Cell Mol Life Sci
, vol.61
, pp. 19-34
-
-
Magni, G.1
Amici, A.2
Emanuelli, M.3
Orsomando, G.4
Raffaelli, N.5
Ruggieri, S.6
-
4
-
-
0034700636
-
The pharmacokinetics and pharmacodynamics of agents proven to raise high-density lipoprotein cholesterol
-
Piepho R.W. The pharmacokinetics and pharmacodynamics of agents proven to raise high-density lipoprotein cholesterol. Am J Cardiol 86 (2000) 35L-40L
-
(2000)
Am J Cardiol
, vol.86
-
-
Piepho, R.W.1
-
5
-
-
34447324420
-
-
Fossler M. WN Analysis of IR and ER NUA data. FDA memorandum dated June 17, 1997. Available under Freedom of Information Act.
-
-
-
-
6
-
-
34447310326
-
A pharmacokinetic/pharmacodynamic model of the vasodilatory effects of niacin
-
Fossler M.J. A pharmacokinetic/pharmacodynamic model of the vasodilatory effects of niacin. Clin Pharmacol Ther 63 (1998) 161
-
(1998)
Clin Pharmacol Ther
, vol.63
, pp. 161
-
-
Fossler, M.J.1
-
7
-
-
0024799035
-
Pharmacokinetics of nicotinic acid-salicylic acid interaction
-
Ding R.W., Kolbe K., Merz B., et al. Pharmacokinetics of nicotinic acid-salicylic acid interaction. Clin Pharmacol Ther 46 (1989) 642-647
-
(1989)
Clin Pharmacol Ther
, vol.46
, pp. 642-647
-
-
Ding, R.W.1
Kolbe, K.2
Merz, B.3
-
9
-
-
33745501028
-
The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target
-
Offermanns S. The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target. Trends Pharm Sci 27 (2006) 384-390
-
(2006)
Trends Pharm Sci
, vol.27
, pp. 384-390
-
-
Offermanns, S.1
-
10
-
-
31044448925
-
GPR 109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing
-
Benyo Z., Gille A., Kero J., et al. GPR 109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. J Clin Invest 115 (2005) 3634-3640
-
(2005)
J Clin Invest
, vol.115
, pp. 3634-3640
-
-
Benyo, Z.1
Gille, A.2
Kero, J.3
-
11
-
-
33751087034
-
Nicotinic acid-induced flushing is mediated by activation of epidermal Langerhans cells
-
Benyo Z., Gille A., Benett C., Clausen B.E., and Offermanns S. Nicotinic acid-induced flushing is mediated by activation of epidermal Langerhans cells. Mol Pharm 70 (2006) 1844-1849
-
(2006)
Mol Pharm
, vol.70
, pp. 1844-1849
-
-
Benyo, Z.1
Gille, A.2
Benett, C.3
Clausen, B.E.4
Offermanns, S.5
-
13
-
-
0003293442
-
Molecular identification of high and low affinity receptors for nicotinic acid
-
Wise A., Foord S.M., Fraser N.J., et al. Molecular identification of high and low affinity receptors for nicotinic acid. J Biol Chem 278 (2003) 9869-9874
-
(2003)
J Biol Chem
, vol.278
, pp. 9869-9874
-
-
Wise, A.1
Foord, S.M.2
Fraser, N.J.3
-
15
-
-
0026695006
-
Differences in metabolism of time-release and unmodified nicotinic acid: explanation of the differences in hypolipidemic action?
-
Stern R.H., Freeman D., and Spence J.D. Differences in metabolism of time-release and unmodified nicotinic acid: explanation of the differences in hypolipidemic action?. Metabolism 41 (1992) 879-881
-
(1992)
Metabolism
, vol.41
, pp. 879-881
-
-
Stern, R.H.1
Freeman, D.2
Spence, J.D.3
|